XRTX - XORTX Therapeutics gains 180-day extension from Nasdaq to regain $1.00 bid price compliance
2025-10-21 01:44:42 ET
XORTX Therapeutics ( NASDAQ: XRTX ) has announced that it has received an extension notice from the Nasdaq Stock Market, granting the company an additional 180 days to meet the exchange’s minimum bid price requirement of $1.00 per share....
XORTX Therapeutics gains 180-day extension from Nasdaq to regain $1.00 bid price compliance